Halberd Corporation (HALB)
- Previous Close
0.0051 - Open
0.0051 - Bid 0.0045 x --
- Ask 0.0051 x --
- Day's Range
0.0045 - 0.0051 - 52 Week Range
0.0030 - 0.0121 - Volume
1,114,689 - Avg. Volume
824,273 - Market Cap (intraday)
3.243M - Beta (5Y Monthly) -4.05
- PE Ratio (TTM)
-- - EPS (TTM)
-0.0000 - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Halberd Corporation, a biotech company, develops treatments for neurodegenerative diseases. It offers treatments for post traumatic stress disorder/chronic traumatic encephalopathy, Alzheimer's and Parkinson's disease, cancer, blood-borne, and cerebrospinal fluid related diseases. The company was incorporated in 2009 and is based in Jackson Center, Pennsylvania.
halberdcorporation.comRecent News: HALB
View More
Performance Overview: HALB
Trailing total returns as of 9/30/2024, which may include dividends or other distributions. Benchmark is
.YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: HALB
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: HALB
View MoreValuation Measures
Market Cap
3.24M
Enterprise Value
3.39M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
1.01k
Price/Book (mrq)
--
Enterprise Value/Revenue
1.24k
Enterprise Value/EBITDA
-3.50
Financial Highlights
Profitability and Income Statement
Profit Margin
0.00%
Return on Assets (ttm)
--
Return on Equity (ttm)
--
Revenue (ttm)
6.94k
Net Income Avi to Common (ttm)
-1.71M
Diluted EPS (ttm)
-0.0000
Balance Sheet and Cash Flow
Total Cash (mrq)
8.16k
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
--
Company Insights: HALB
HALB does not have Company Insights